ClinicalTrials.Veeva

Menu

Evaluation of Accuvein in Cirrhotics Patients (CIRRVVUS)

C

Caen University Hospital

Status

Enrolling

Conditions

Liver Cirrhosis

Treatments

Device: Cannulation with AccuVein AV400

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The objective of this study is to evaluate the effectiveness of AccuVein AV400 to facilitate placement of peripheral intravenous catheters in cirrhotic adults by comparing the success rate of the first attempt to install a peripheral venous catheter with or without AccuVein AV400®.

Enrollment

280 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient older than 18 years old
  • Patient presenting a liver cirrhosis
  • Patient requiring the placement of a venous peripheral catheter
  • Patient informed and giving free and informed consent
  • Patient affiliated to a French social security scheme

Exclusion criteria

  • Patient under 18 years old
  • Patient unable to give consent
  • Patient under guardianship or curatorship

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

280 participants in 2 patient groups

Experimental : Cannulation with AccuVein AV400
Experimental group
Description:
Cirrhotic patients benefit from the support of a venous illumination device for each peripheral venous cannulation
Treatment:
Device: Cannulation with AccuVein AV400
Control
No Intervention group
Description:
Cirrhotic patients benefit from the standard technique of peripheral veinous catheter placement.

Trial contacts and locations

1

Loading...

Central trial contact

Nelly Orliac; Philippe Moiteaux

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems